EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38? Kinase Inhibitor Neflamapimod on the Neurodegenerative Process

0
5

EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38? Kinase Inhibitor Neflamapimod on the Neurodegenerative Process

LEAVE A REPLY

Please enter your comment!
Please enter your name here